Boston Scientific Deferred Tax Assets increased by 0.2% to $3.68B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.5%, from $3.66B to $3.68B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets shows a downward trend with a -2.7% CAGR.
An increase may signal future tax relief, while a decrease suggests the utilization of tax assets or valuation allowance adjustments.
This represents the future tax benefits that the company expects to realize due to temporary differences between the boo...
Common in global mining; peers with significant capital expenditures often hold substantial deferred tax assets.
non_current_assets_deferred_income_tax_assets_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.04B | $4.05B | $4.14B | $4.10B | $4.06B | $4.02B | $3.94B | $3.90B | $3.87B | $3.84B | $3.84B | $3.79B | $3.80B | $3.82B | $3.66B | $3.68B | $3.78B | $3.67B | $3.68B |
| QoQ Change | — | +0.3% | +2.3% | -1.0% | -1.0% | -1.0% | -1.9% | -1.1% | -0.9% | -0.6% | +0.0% | -1.3% | +0.2% | +0.4% | -4.2% | +0.6% | +2.8% | -2.9% | +0.2% |
| YoY Change | — | — | — | — | +0.6% | -0.8% | -4.8% | -4.9% | -4.8% | -4.4% | -2.6% | -2.8% | -1.7% | -0.6% | -4.8% | -3.1% | -0.6% | -3.9% | +0.5% |